Quest Diagnostics DGX All other operating segments — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Quest Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quest Diagnostics's all other operating segments — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Quest Diagnostics's all other operating segments — D&A?
- Quest Diagnostics (DGX) reported all other operating segments — D&A of $3M in Q1 2026.
- How has Quest Diagnostics's all other operating segments — D&A changed year-over-year?
- Quest Diagnostics's all other operating segments — D&A decreased by 25.0% year-over-year, from $4M to $3M.
- What is the long-term trend for Quest Diagnostics's all other operating segments — D&A?
- Over 4 years (2021 to 2025), Quest Diagnostics's all other operating segments — D&A has grown at a 8.8% compound annual growth rate (CAGR), from $10M to $14M.
- What does all other operating segments — D&A mean?
- This represents the non-cash expense allocated to the wear and tear of tangible assets and the expiration of intangible assets specifically within the 'all other' business segments. It provides insight into the capital intensity of these secondary operations. Tracking this helps in understanding the underlying cash flow generation of these specific units.